Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
acute ischemic stroke
Biotech
No remedy for DiaMedica as FDA maintains hold on stroke trial
DiaMedica Therapeutics’ trial remains on hold after the FDA requested more data to allay its concerns about how the stroke drug is administered.
James Waldron
Oct 27, 2022 9:30am
Route 92 collects $111M for its brain clot-clearing devices
Dec 15, 2021 10:22am
FDA panel rejects BrainsGate neurostim implant for stroke
Dec 14, 2021 10:10am
Stroke trials don't match prevalence of disease in women: study
Oct 26, 2021 11:07am
Blocking a 'rogue' inflammatory response during stroke
Sep 22, 2021 9:30am
Lumosa's stroke drug lowers risk of deadly complication
Aug 4, 2021 10:35am